Kyle Kline - 18 Jul 2025 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Senior Vice President, CFO
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
18 Jul 2025
Transactions value $
$0
Form type
4
Filing time
27 Aug 2025, 18:10:20 UTC
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kline Kyle Senior Vice President, CFO VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON /s/ Kelly G. Huller, Attorney-in-Fact 27 Aug 2025 0002080625

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Award $0 +20.9K $0.00 20.9K 18 Jul 2025 Class A Common Stock 20.9K $56.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on July 18, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 18, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.